Bouthry E, Picone O, Hamdi G, Grangeot-Keros L, Ayoubi JM, Vauloup-Fellous C, 2014. Rubella and pregnancy: diagnosis, management and outcomes. Prenat Diagn 34: 1246–1253.
World Health Organization, 2016. Global Vaccine Action Plan (GVAP) Secretariat report 2015. Available at: http://www.who.int/immunization/global_vaccine_action_plan/previous_secretariat_reports_immunization_scorecards/en/. Accessed July 25, 2016.
Lin CC, Yang CY, Shih YL, Hsu HW, Yang TH, Cheng YW, Chang CF, Hsieh LC, Chen BH, Lee CH, Huang YL, 2011. Rubella seroepidemiology and estimations of the catch-up immunization rate and persistence of antibody titers in pregnant women in Taiwan. BJOG 118: 706–712.
Pham VH, Nguyen TV, Nguyen TT, Dang LD, Hoang NH, Nguyen TV, Abe K, 2013. Rubella epidemic in Vietnam: characteristic of rubella virus genes from pregnant women and their fetuses/newborns with congenital rubella syndrome. J Clin Virol 57: 152–156.
Chen M, Zhu Z, Liu D, Huang G, Huang F, Wu J, Zhang T, Xu W, Pang X, 2013. Rubella epidemic caused by genotype 1E rubella viruses in Beijing, China, in 2007–2011. Virol J 10: 122.
Portella G, Galli C; Multicenter Italian Group for Hospital ToRC evaluation, 2010. Multicentric evaluation of two chemiluminescent immunoassays for IgG and IgM antibodies towards rubella virus. J Clin Virol 49: 105–110.
De Paschale M, Manco MT, Paganini A, 2012. Rubella antibody screening during pregnancy in an urban area of northern Italy. Infect Dis Rep 4: 17.
Ramos JM, Milla A, Rodriguez JC, Gutierrez F, 2012. Rubella immune status among immigrant and nonimmigrant women in Spain. J Med Virol 84: 548–550.
McElroy R, Laskin M, Jiang D, Shah R, Ray JG, 2009. Rates of rubella immunity among immigrant and non-immigrant pregnant women. J Obstet Gynaecol Can 31: 409–413.
Tookey PA, Cortina-Borja M, Peckham CS, 2002. Rubella susceptibility among pregnant women in north London, 1996–1999. J Public Health Med 24: 211–216.
Sathanandan D, Gupta L, Liu B, Rutherford A, Lane J, 2005. Factors associated with low immunity to rubella infection on antenatal screening. Aust N Z J Obstet Gynaecol 45: 435–438.
Cheng WY, Wang HC, Liu MT, Wu HS, 2013. Molecular surveillance of rubella viruses in Taiwan from 2005 to 2011. J Med Virol 85: 745–753.
World Health Organization, 2016. Rubella reported cases. Available at: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencerubella.html. Accessed September 25, 2016.
Pfaff G, 2013. Strategies for measles and rubella elimination in the World Health Organization European Region. Eur J Public Health 23 (Suppl 1): 52.
Alzeidan RA, Wahabi HA, Fayed AA, Esmaeil SA, Amer YS, 2013. Postpartum rubella vaccination for sero-negative women. Cochrane Database Syst Rev CD010752.
Lai FY, Dover DC, Lee B, Fonseca K, Solomon N, Plitt SS, Jaipaul J, Tipples GA, Charlton CL, 2015. Determining rubella immunity in pregnant Alberta women 2009–2012. Vaccine 33: 635–641.
Vilajeliu A, García-Basteiro AL, Valencia S, Barreales S, Oliveras L, Calvente V, Goncé A, Bayas JM, 2015. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain. Vaccine 33: 1767–1772.
Matthews L, Gray D, Gray S, Lawrance L, 2013. Post-partum MMR immunization rates in rubella-susceptible antenatal women. Br J Midwifery 21: 16–22.
Lin CC, Yang CY, Shih CT, Chen BH, Huang YL, 2010. Rubella seroepidemiology and catch-up immunization among pregnant women in Taiwan: comparison between women born in Taiwan and immigrants from six countries in Asia. Am J Trop Med Hyg 82: 40–44.